Preview Mode Links will not work in preview mode

Keeping Current CME

May 31, 2023

Are you up to date on treating patients with advanced melanoma with the latest checkpoint inhibitor combination lymphocyte activating gene 3 (LAG3)/programmed cell death protein 1 (PD-1)?

Credit available for this activity expires: 5/30/24
Earn Credit / Learning Objectives & Disclosures: